MAY 3, 2016

ACC: Nonstatin Therapies May Be Appropriate for Certain High-Risk Patients

A new expert consensus document states that health care providers might consider adding nonstatin therapies to help reduce cholesterol in patients at high risk for cardiovascular events (JACC 2016 Apr 1. [Epub ahead of print]).

The document is intended to address current gaps in recommendations for reducing low-density lipoprotein cholesterol (LDL-C) and to provide practical guidance for clinicians in situations that were not covered by the 2013 guideline issued by the American College

To read the full story, Log in or Sign up for a Free Account

Online First